Thursday, February 2

Tag: BioSpace


Thermo Fisher Scientific’s Clinical Research Business Named a Leader in Decentralized Clinical Trial Solutions by ISG

WILMINGTON, N.C.--(BUSINESS WIRE)-- The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been distinguished for industry leadership in digital and decentralized clinical trial solutions by Information Services Group (ISG), a leading global technology research and advisory firm. The business was recognized as an ISG Provider Lens Leader for its digital transformation services, including customer solutions for clinical development and patient engagement. This marks the second consecutive year the business has been acknowledged by ISG. In its 2021 ISG Provider Lens™ Life Sciences Digital Services Global Report, ISG recognized Thermo Fisher’s clinical research business with a clinical development leader designation for its skill and dexteri...
Biobohemia Pushes Forward Antigenic Essence Technology in Released Paper

Biobohemia Pushes Forward Antigenic Essence Technology in Released Paper

CAMBRIDGE, MA / ACCESSWIRE / May 10, 2022 / Biobohemia's scientists share in a released paper ("Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen Compositions") the experience gained over the past year in advancing antigen essence technology, including that related to relationships with contract manufacturing organizations, the upgrading of existing experimental cancer vaccines, and the legal and ethical aspects of the technology.Biobohemia is a pioneer in work on antigenic essence, a new technology for the creation of cancer vaccines. Although this technology has been recognized as a promising platform for this purpose ("Cancer Vaccine Platforms", Report 2022), its novelty poses unique challenges. The released paper describes the experience gained by the...